BRTX Insider Trading Activity and SEC Form 4 Filings
BRTX insider trading summary
No open-market insider purchases or sales of BioRestorative Therapies, Inc. (BRTX) have been reported on SEC Form 4 in the past 12 months.
Latest BRTX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 28, 2024 | Dale Broadrick | Insider | Sell | $2K (1,112 @ $1.58) |
| Apr 9, 2024 | Francisco Silva | VP of Research and Development | Buy | $8K (6,600 @ $1.25) |
| Apr 8, 2024 | Francisco Silva | VP of Research and Development | Buy | $1K (1,232 @ $1.17) |
| Apr 8, 2024 | Francisco Silva | VP of Research and Development | Buy | $538 (476 @ $1.13) |
| Feb 9, 2024 | Dale Broadrick | Insider | Buy | $114K (86,041 @ $1.32) |
| Feb 8, 2024 | Dale Broadrick | Insider | Buy | $112K (83,626 @ $1.34) |
| Feb 8, 2024 | Dale Broadrick | Insider | Buy | $92K (73,959 @ $1.25) |
| Feb 7, 2024 | Dale Broadrick | Insider | Buy | $50K (36,374 @ $1.38) |
| Dec 1, 2023 | Dale Broadrick | Insider | Sell | $469 (250 @ $1.88) |
| Nov 27, 2023 | Dale Broadrick | Insider | Sell | $525 (278 @ $1.89) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.